GI
UTMD icon

GAMMA Investing’s Utah Medical Products UTMD Stock Holding History

GAMMA Investing’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Buy
225
+88
+64% +$5.85K ﹤0.01% 2976
2026
Q1 		$8.49K Buy
137
+66
+93% +$4.16K ﹤0.01% 3157
2025
Q4 		$3.97K Sell
71
-51
-42% -$2.96K ﹤0.01% 3376
2025
Q3 		$7.68K Buy
122
+99
+430% +$5.86K ﹤0.01% 3000
2025
Q2 		$1.31K Sell
23
-49
-68% -$2.67K ﹤0.01% 3486
2025
Q1 		$4.04K Buy
72
+69
+2,300% +$4.13K ﹤0.01% 3169
2024
Q4 		$184 Sell
3
-26
-90% -$1.68K ﹤0.01% 3714
2024
Q3 		$1.94K Buy
+29
New +$1.97K ﹤0.01% 3078
2024
Q1 		– Sell
-1
Closed -$79 – 3373
2023
Q4 		$79 Buy
+1
New +$83 ﹤0.01% 3151

Other funds holding UTMD

VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

GAMMA Investing's UTMD Position: Q2 2026 in Review

GAMMA Investing increased its Utah Medical Products (UTMD) stake by 64% in Q2 2026, buying an estimated $5.85K and bringing the position to 225 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

GAMMA Investing first reported a position in UTMD in Q4 2023 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • GAMMA Investing held 225 shares of Utah Medical Products worth $15.5K as of Q2 2026.
  • GAMMA Investing bought 88 Utah Medical Products shares in Q2 2026, an estimated $5.85K.
  • Utah Medical Products made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2976 holding.
  • GAMMA Investing first reported a position in Utah Medical Products in Q4 2023 and has held it in 9 quarters since.
  • 7 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.